Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
TikTok Rolls Out New Guidelines Restricting 'Deepfakes'
TikTok is banning deepfakes amid increasing pressure from the U.S. government over privacy and security concerns. CEO Shou Zi Chew announced the policy in a TikTok video on Tuesday two days ahead of his scheduled appearance before congress.
Load More